Charles Zhu

Stock Analyst at LifeSci Capital

(2.76)
# 1,855
Out of 4,883 analysts
25
Total ratings
54.55%
Success rate
20.76%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Charles Zhu

Crescent Biopharma
Jun 18, 2025
Initiates: Outperform
Price Target: $22
Current: $15.30
Upside: +43.79%
Repare Therapeutics
Dec 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $1.42
Upside: -
Tango Therapeutics
Nov 7, 2024
Maintains: Buy
Price Target: $18$8
Current: $5.43
Upside: +47.33%
MacroGenics
Nov 7, 2023
Upgrades: Buy
Price Target: $12
Current: $1.36
Upside: +782.35%
Merus
Aug 8, 2023
Maintains: Buy
Price Target: $46$48
Current: $52.52
Upside: -8.61%
Nuvalent
Jul 24, 2023
Initiates: Buy
Price Target: $56
Current: $77.92
Upside: -28.13%
Protara Therapeutics
Jul 10, 2023
Assumes: Buy
Price Target: $22
Current: $2.82
Upside: +681.53%
Cogent Biosciences
Jun 13, 2023
Reiterates: Buy
Price Target: $26
Current: $9.35
Upside: +178.07%
IDEAYA Biosciences
Mar 8, 2023
Reiterates: Buy
Price Target: $32
Current: $21.17
Upside: +51.16%
Zymeworks
May 5, 2022
Upgrades: Buy
Price Target: $14
Current: $13.08
Upside: +7.03%